Sources | Names Used |
---|---|
CTRPv2 | BRD-K55116708 |
PharmacoGx | BRD-K55116708 |
Database | Identifier |
---|---|
Smiles: | C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)Nc3ccccc3N)Oc4c(NC(=O)Nc5ccccc5)cccc4C1=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPM1K | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | LRP5L | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | HIVEP2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | HIST1H2AE | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | XKR3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | TAS2R41 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | TOP1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | CCDC168 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | THEMIS | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | CD164L2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |